Ryvu Therapeutics Statistics

Total Valuation

WSE:RVU has a market cap or net worth of PLN 749.09 million. The enterprise value is 633.69 million.

Market Cap	749.09M
Enterprise Value	633.69M

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

WSE:RVU has 23.12 million shares outstanding. The number of shares has increased by 0.97% in one year.

Current Share Class	n/a
Shares Outstanding	23.12M
Shares Change (YoY)	+0.97%
Shares Change (QoQ)	-4.26%
Owned by Insiders (%)	23.80%
Owned by Institutions (%)	52.82%
Float	15.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.35
PB Ratio	5.21
P/TBV Ratio	5.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.69
EV / Sales	6.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.68

Financial Position

The company has a current ratio of 2.52, with a Debt / Equity ratio of 0.77.

Current Ratio	2.52
Quick Ratio	2.34
Debt / Equity	0.77
Debt / EBITDA	n/a
Debt / FCF	-0.82
Interest Coverage	-32.03

Financial Efficiency

Return on equity (ROE) is -55.24% and return on invested capital (ROIC) is -29.11%.

Return on Equity (ROE)	-55.24%
Return on Assets (ROA)	-19.50%
Return on Invested Capital (ROIC)	-29.11%
Return on Capital Employed (ROCE)	-45.03%
Revenue Per Employee	310,857
Profits Per Employee	-339,741
Employee Count	328
Asset Turnover	0.26
Inventory Turnover	11.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.47% in the last 52 weeks. The beta is 0.80, so WSE:RVU's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	-36.47%
50-Day Moving Average	24.19
200-Day Moving Average	40.68
Relative Strength Index (RSI)	71.50
Average Volume (20 Days)	167,494

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:RVU had revenue of PLN 101.96 million and -111.44 million in losses. Loss per share was -4.82.

Revenue	101.96M
Gross Profit	82.38M
Operating Income	-121.97M
Pretax Income	-111.14M
Net Income	-111.44M
EBITDA	-111.76M
EBIT	-121.97M
Loss Per Share	-4.82

Full Income Statement

Balance Sheet

The company has 225.93 million in cash and 110.53 million in debt, giving a net cash position of 115.40 million or 4.99 per share.

Cash & Cash Equivalents	225.93M
Total Debt	110.53M
Net Cash	115.40M
Net Cash Per Share	4.99
Equity (Book Value)	143.88M
Book Value Per Share	6.22
Working Capital	164.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -129.48 million and capital expenditures -5.90 million, giving a free cash flow of -135.38 million.

Operating Cash Flow	-129.48M
Capital Expenditures	-5.90M
Free Cash Flow	-135.38M
FCF Per Share	-5.86

Full Cash Flow Statement

Margins

Gross margin is 80.80%, with operating and profit margins of -119.63% and -109.29%.

Gross Margin	80.80%
Operating Margin	-119.63%
Pretax Margin	-109.00%
Profit Margin	-109.29%
EBITDA Margin	-109.61%
EBIT Margin	-119.63%
FCF Margin	n/a

Dividends & Yields

WSE:RVU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.97%
Shareholder Yield	-0.97%
Earnings Yield	-14.88%
FCF Yield	-18.07%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

WSE:RVU has an Altman Z-Score of 2.4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.4
Piotroski F-Score	n/a